HEALTH● LOWJun 26 · Jun 26, 2026, 6:40 PM
China Approves CARsgen’s CAR-T Treatment for Stomach Cancer
Human Progress
“China’s drug regulator said on Monday it has approved a CARsgen Therapeutics treatment for stomach cancer, a new milestone for CAR-T therapies, which engineer patients’ immune cells to recognise and kill cancer cells. The injection, also known as satri-cel, is globally the first approved CAR-T cell therapy for solid tumors, CARsgen CEO Li Zonghai told […] The post China Approves CARsgen’s CAR-T Treatment for Stomach Cancer appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH29m agoMaharashtra FDA issues order to curb sale, repackaging of expired food itemsThe HinduHEALTH57m agoEpidermolysis Bullosa and patients' fight against stigmatization: "Calling us butterfly skin doesn't help at all"ClarínHEALTH1h agoEbola scare in Adamawa: NCDC confirms negative testsVanguard NigeriaHEALTH4h agoCONHESS: JOHESU mobilises health workers for showdown with FGVanguard Nigeria